As several sedative-hypnotics are distributed illegally and are available domestically through media like the internet, their abuse is becoming a serious social problem. In the present study, four legal cases involving abuse of diazepam, midazolam, and/or zolpidem were proved by hair analysis using a simultaneous quantification method for the determination of diazepam (and its metabolites), lorazepam, midazolam, and zolpidem, which are often illegally abused in Korea, in hair that was developed and validated. Drugs and metabolites in hair were extracted using methanol followed by solid-phase extraction. The extracts were derivatized with N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) and analyzed using gas chromatography-mass spectrometry in selected ion monitoring mode. The validation parameters of the method, including selectivity, linearity, limits of detection and quantification (LOQ), recovery, intra-and interassay precision and accuracy, and processed sample stability, were satisfactory. Moreover, the developed method was successfully applied to actual cases. In case 1, which involved a pop singer who was detained for suspected drug abuse, the concentrations of diazepam and nordiazepam were 5.7 and 2.0 ng/mg in nonpigmented hair and 6.6 and 1.8 ng/mg in pigmented hair, respectively. In case 2, 0.4 ng/mg zolpidem was detected in hair from a drug abuser who purchased illegally through the internet, and 0.2 ng/mg midazolam was detected in hair from an illegal drug seller in case 3. In case 4, diazepam (lower than the LOQ), nordiazepam (0.7 ng/mg), and zolpidem (0.7 ng/mg) were detected in hair from a medical doctor who abused drugs using forged prescriptions.
Introduction
Benzodiazepine and non-benzodiazepine sedative-hypnotics (Z drugs) have been commonly prescribed by medical professionals for the treatment of various mental illnesses, particularly for anxiety and insomnia. However, due to their inherent adverse effects of a high degree of tolerance and dependence, these drugs are often abused by individuals. Moreover, as these drugs are distributed illegally and available through media like the internet, their abuse is becoming a serious social problem. Recently, biological samples, including hair, collected from legal cases involving abuse of benzodiazepines and Z drugs (e.g., abuse by medical professionals, cases of drugs stolen from the pharmacy for abuse purposes, etc.) have often been submitted to our laboratory for drug analysis.
Hair has been identified as a good analytical specimen and probative evidence for chronic drug use. Results obtained from the analysis of hair specimens provide sufficient evidence of previous drug usage as well as information on the duration for which the drug was used, depending on the growth rate of hair (approximately 1 cm/month), and thus can serve as key evidence in legal decisions.
The efficiency of benzodiazepine incorporation into hair was previously studied using rats (1-4). Scott and Nakahara (1) assessed eight benzodiazepines (chlordiazepoxide, diazepam, estazolam, flunitrazepam, flurazepam, medazepam, oxazepam, and triazolam) in rat hair and also calculated their incorporation rates (ICR). The ICRs ranged from 0.002 (flunitrazepam) to 0.049 (flurazepam), and more basic benzodiazepines, such as flurazepam and medazepam, were incorporated more highly into hair (1) . Another group of researchers demonstrated the incorporation of alprazolam, estazolam, midazolam, and their metabolites into rat hair (2) . Triazolam and its metabolites were also detected in both rat hair and hair from a Halcion abuser. The concentrations of triazolam and its metabolites, 1-hydroxymethyltriazolam (1-HT) and 4-hydroxytriazolam (4-HT), were higher in black hair shaft than in white. Moreover, the concentrations of 1-HT and 4-HT were higher than that of triazolam in black hair shaft; in white hair shaft and hair root, triazolam was detectable, but the metabolites 1-HT and 4-HT were not (3) . Recent studies about the determination of benzodiazepines in human hair have mostly been conducted to aid (5-7) and, more recently, to prove single drug exposure in drugfacilitated crimes (8, 9) .
In the present study, four legal cases involving abuse of diazepam, midazolam, and/or zolpidem were proved by hair analysis using a simultaneous quantification method that was developed and validated for the determination of diazepam (and its metabolites), lorazepam, midazolam, and zolpidem, which are often illegally abused in Korea, in hair.
Materials and Methods

Chemicals
All 
Sample preparation
Diazepam and its metabolites, lorazepam, midazolam, and zolpidem were extracted and purified from hair using a previously described method (5) with suitable modifications. First, the hair samples were washed twice with distilled water and methanol, respectively. After drying, they were cut into very small pieces of less than 1 mm. Then, they were weighed accurately (approximately 30 mg) and incubated in methanol at 38°C for 16 h. Diazepam-d 5 and lorazepam-d 4 were used as internal standards. The extract was evaporated to dryness under a stream of nitrogen, and the residue was reconstituted in 3 mL of pH 6 phosphate buffer. Then, solid-phase extraction (SPE) was carried out with this solution using a CLEAN SCREEN column (United Chemical Technologies, Bristol, PA) installed on automatic SPE equipment, RapidTrace™ (Zymark, Hopkinton, MA). The column was conditioned with 2 mL of methanol, followed by 2 mL of distilled water and 2 mL of 0.1 M phosphate buffer (pH 6). The sample was loaded on the column and pulled through at a rate of 2 mL/min. After that, the column was sequentially washed with 3 mL of distilled water, 1 mL of 0.1 M hydrochloric acid, and 2 mL of hexane. The column was dried for 3 min using nitrogen. The sample was then eluted from the column with 3 mL of dichloromethane/isopropanol/ammonium hydroxide (78:20:2). The eluent was evaporated to dryness under nitrogen at 45°C. The residue was derivatized with 50 μL of MSTFA at 90°C for 20 min and submitted for gas chromatography-mass spectrometry (GC-MS).
GC-MS analysis
Diazepam and its metabolites, lorazepam, midazolam, and zolpidem in hair were analyzed on an Agilent 7890A/5975C GC-MS system. The GC was equipped with a 30-m (0.25-mm i.d., 0.25-μm film thickness) HP-5MS capillary column. The inlet temperature was 250°C, and the helium flow rate was 1.0 mL/min. The oven was programmed to operate at an initial temperature of 100°C for 1 min, to increase to 300°C at a heating rate of 10°C/min, and finally to hold for 15 min. The MS was operated in selected ion monitoring (SIM) mode. The identification and quantification were performed by monitoring the ions listed in Table I 
Validation study
The analytical method was validated using fortified drug-free hair as described in an earlier study (10) , and the following parameters were evaluated: selectivity, linearity, limits of detection (LOD) and quantification (LOQ), recovery, intra-and interassay precision and accuracy, and processed sample stability. In order to demonstrate linearity, five sets of calibrators (5-100 ng total concentration for diazepam and zolpidem and 10-100 ng total concentration for others) were prepared and analyzed. For the LOD and LOQ determination, drug-free hair samples fortified with each benzodiazepine and zolpidem at concentrations below 10 ng were evaluated. The analyte concentration at which the signal-to-noise ratio was greater than 3 was chosen for the LOD, and that with less than 20% coefficient of variation for precision and less than ±20% for bias was selected for the LOQ. The recovery was determined by comparing the analysis of extracted and non-extracted spiked samples at low (10 ng) and high (100 ng) concentrations. Method precision and accuracy were examined by analyzing drug-free hair samples fortified with low and high concentrations of each analyte, respectively. Five sets of each sample were analyzed on five different days. In order to examine the processed sample stability, eight hair samples fortified at low and high concentrations were prepared as described in the Sample preparation section and pooled. Then, each aliquot was injected at 2.5-h intervals over 20 h. * Abbreviations: CV, coefficient of variation; SD, standard deviation; SE, standard error; R 2 , regression coefficient; LOD, limit of detection; and LOQ, limit of quantification. † 5-100 ng total for diazepam, 10-100 ng total for others, n = 5. 
Results and Discussion
Results of the validation of the method are summarized in Table II . No interferences were detected at the retention times of the analytes and the internal standards. Results of intra-and interassay precision and accuracy were satisfactory, that is, less than 20% for precision (except for 20.8% of oxazepam for interassay) and within ±20% for accuracy at the low concentration (10 ng) and less than 10% for precision and within ±15% for accuracy at the high concentration (100 ng), and were in accord with the acceptance criteria (10) . The recovery was 71-103% for all analytes. The regression coefficients of the calibration curves were higher than 0.995 in every occasion. The LODs were 5 ng for nordiazepam, oxazepam, diazepam, lorazepam, and temazepam and 10 ng for midazolam and zolpidem. The LOQs were 5 ng for diazepam and 10 ng for others. Based on the linear regression analysis of peak area plotted versus injection times, processed sample stability was also satisfactory, that is, negative slopes were not indicated at the low and high concentrations of all the analytes including the internal standards.
Removal of interference is a key step in hair extraction to increase sensitivity for the detection of drugs in hair. Generally, hair extraction by aqueous acids or NaOH is cleaner than that by methanol, but hydrolysis during sample preparation should be noticed (11) . In our preliminary study, hair was treated with 0.1 N hydrochloric acid, which resulted in partial hydrolysis of oxazepam (higher than 70%). Therefore, methanol extraction was used for the current study. Nevertheless, the reproducibility of oxazepam in low concentration (10 ng) was not as good as those of other analytes.
Hair samples from four cases were submitted to our laboratory in order to provide evidence for illegal abuse of sedativehypnotics. In case 1, a pop singer who was detained for suspected drug abuse, the respective concentrations of diazepam and nordiazepam were 5.7 and 2.0 ng/mg in nonpigmented hair and 6.6 and 1.8 ng/mg in pigmented hair. In case 2, 0.4 ng/mg zolpidem was detected in hair from a drug abuser who purchased the drug illegally through the internet, and 0.2 ng/mg midazolam was detected in hair from case 3 of an illegal drug seller. In hair from case 4, a medical doctor who abused drugs using forged prescriptions, diazepam (lower than the LOQ), nordiazepam (0.7 ng/mg), and zolpidem (0.7 ng/mg) were detected (Table III) . In previous studies, the highest concentrations of diazepam and nordiazepam in hair segments from 16 postmortem cases were 0.68 and 2.26 ng/mg, respectively (6), and those in 10 non-segmented postmortem hair samples were 0.68 and 0.97 ng/mL, respectively (7) . In another study, the concentrations of diazepam and nordiazepam in hair segments from eight psychiatric patients ranged from 0.05 to 1.41 ng/mg and from 0.07 to 0.60 ng/mg, respectively (12) . Compared with those concentrations, the diazepam and nordiazepam concentrations in hair from case 1 were much higher, and those from case 4 were similar. It is presumed that case 1 involved a heavy drug user. Little data regarding the concentrations of zolpidem and midazolam in hair from drug abusers are available.
According to the police reports, the former three drug offenders in the current study had used sedative-hypnotics chronically without a prior prescription. As online drug shopping via the internet has recently become popular because of its ease and anonymity, these drugs of abuse have spread quickly, as shown in case 2. Even though melanin is known to play an important role in the incorporation of most drugs into hair (11) , no significant difference was observed in the concentrations of diazepam and nordiazepam between nonpigmented and pigmented hair in case 1. Because the hair length in case 1 was relatively long (10-35 cm), this result may be due to prolonged sweat and sebum secretion.
